Skip to main content

$32.81 0.28 (0.86%)

High

$32.86

Low

$32.55

Trades

6,994

Turnover

$36,021,783

Volume

1,098,777
30 June 2023 at 4:12pm
Register to track RMD and receive email alerts.

ASX Announcements (7d)

-

Twitter Mentions (7d)

0+

AFR Articles (7d)

-

News Articles (7d)

1+
Subject
stock_company_name Ann: ResMed Announces Results for the Second Quarter of FY2023

stock_company_name Ann: RMD to Report Second Quarter Fiscal 2023 Results

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: FORM 8-K Annual Stockholders Meeting

stock_company_name Ann: Update - Dividend/Distribution - RMD

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: FORM 10Q for Qtr ended September, 2022

stock_company_name Article: ASX to slip; Macquarie posts $2.3b half-year profit

stock_company_name Ann: Dividend/Distribution - RMD

stock_company_name Ann: ResMed Announces Results for the First Quarter of FY2023

stock_company_name Ann: RMD to Report First Quarter Fiscal 2023 Results

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: Notice of Annual General Meeting Additional Materials

stock_company_name Ann: Notice of Annual General Meeting/Proxy Form

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: Update - Dividend/Distribution - RMD

stock_company_name Ann: ResMed Form 10-k Annual Report

stock_company_name Article: ResMed profit jumps after rival’s own goal

stock_company_name Ann: Dividend/Distribution - RMD

stock_company_name Ann: ResMed Announces Results for the Fourth Quarter of FY2022

stock_company_name Article: ASX to fall, Wall St ends mixed on rate clouds

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: RMD to Report Fourth Quarter Fiscal 2022 Results

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: Director Appointment/Resignation

stock_company_name Ann: Form 8-K

stock_company_name Article: Tech buy gets ResMed into German out-of-hospital market

stock_company_name Article: ResMed $US1b German tech buy

stock_company_name Ann: ResMed to Acquire MEDIFOX DAN

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: FORM SD

stock_company_name Ann: Update - Dividend/Distribution - RMD

stock_company_name Ann: Director Appointment/Resignation

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: FORM 10Q for Qtr ended March, 2022

stock_company_name Article: ResMed to strive for ‘sequential growth’ as quarterly disappoints

stock_company_name Ann: Dividend/Distribution - RMD

stock_company_name Ann: ResMed Announces Results for the Third Quarter of FY2022

stock_company_name Ann: RMD to Report Third Quarter Fiscal 2022 Results

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Article: ResMed: no further chip supply squeeze on horizon

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: Update - Dividend/Distribution - RMD

stock_company_name Ann: Statement of CDIs on issue - RMD

stock_company_name Ann: FORM 10Q for Qtr ended December, 2021

stock_company_name Article: Shares rebound; Atlassian soars on profit beat

stock_company_name Article: Atlassian soars on profit beat; Apple, ResMed post record results

stock_company_name Article: ResMed revenue, profit up more than 13pc on ‘extraordinary demand’

stock_company_name Ann: Dividend/Distribution - RMD

Register to track RMD and receive email alerts.